Sponsored by:

Molecular Imaging: Page 496

PET/CT shows slight edge over MRI in melanoma staging
By Jonathan S. Batchelor
VIENNA - A recent prospective study comparing whole-body MRI with whole-body PET/CT in staging newly diagnosed malignant melanoma demonstrated that PET/CT has a slight edge in accuracy, but that both modalities missed local and distant metastases.
March 7, 2006
Philips launches new PET/CT product, ultrasound upgrades at ECR
By AuntMinnie.com staff writers
VIENNA - Multimodality developer Philips Medical Systems unveiled a new PET/CT and a new ultrasound system at the European Congress of Radiology (ECR) this week.
March 5, 2006
AuntMinnie.com Molecular Imaging Radiology Insider
By Jonathan S. Batchelor
March 5, 2006
U.S. agencies launch biomarker initiative
By AuntMinnie.com staff writers
The Food and Drug Administration, the National Cancer Institute, and the Centers for Medicare and Medicaid Services this month announced a new initiative to collaborate on improving the development of cancer therapies and the outcomes for cancer patients through biomarker development and evaluation.
March 1, 2006
SNM disburses technologist, physician grants
By AuntMinnie.com staff writers
The Society of Nuclear Medicine (SNM) recently awarded $58,000 in scholarships and grants for molecular/nuclear medicine technologist students.
February 27, 2006
Gambhir joins Lumera board
Dr. Sanjiv Sam Gambhir of Stanford University in Palo Alto, CA, has joined the board of directors of Lumera, the company reported.
February 27, 2006
Siemens, PETNet buy New England PETNet
By AuntMinnie.com staff writers
Siemens Medical Solutions and subsidiary PETNet Pharmaceuticals have purchased full ownership of the New England PETNet manufacturing and distribution center in Woburn, MA.
February 26, 2006
Imagin Nuclear Partners begins operations
By AuntMinnie.com staff writers
PET and PET/CT imaging center developer Imagin Molecular said that its wholly owned subsidiary Imagin Nuclear Partners has purchased a PET camera from Positron of Houston for its initial joint venture at a New York City medical center.
February 23, 2006
Schering, IBA ink radiopharma deal
By AuntMinnie.com staff writers
German contrast media firm Schering said that its French subsidiary, Schering S.A.S., will transfer the radiopharmaceutical business of CIS bio international to a consortium formed by Ion Beam Applications (IBA), of Louvain-la-Neuve, Belgium, and the Institut National des Radioéléments of Walloon, Belgium.
February 22, 2006
Rubidium-based PET may finally get its due
By Wayne Forrest
After languishing in the clinical shadows for the last 10 years, rubidium is starting to catch the attention of nuclear medicine specialists. The radiopharmaceutical can thank the Centers for Medicare and Medicaid Services (CMS) for its revival.
February 22, 2006
2006 02 22 17 06 07 706
Therapeutic radiopharmaceutical market poised for takeoff
By AuntMinnie.com staff writers
Although U.S. sales of therapeutic radiopharmaceuticals totaled just $57 million in 2005, rapid growth is anticipated over the next five to six years. By 2012, therapeutic radiopharmaceutical product sales should reach $1.9 billion, with high growth continuing beyond that time, according to a recent study by market research firm Bio-Tech Systems.
February 20, 2006
Digirad posts flat revenues, loss in 2005
By AuntMinnie.com staff writers
Nuclear medicine vendor Digirad reported fourth-quarter revenues of $17.4 million, down 2.2% compared with the $17.8 million posted in the fourth quarter last year. For the period (end-December 31), the Poway, CA-based firm had a net loss of $2.8 million, compared with net income of $22,000 last year.
February 16, 2006
Previous Page
Page 496 of 615
Next Page